List of Oral Presentations

The following Oral Presentations will be delivered at Cancer & Autoimmunity 2018:

Speaker Title Institution Country
Gerardo E. Guillén, PhD. Pending Title Center for Genetic Engineering and Biotechnology, CIGB Cuba
Silvio E. Perea, PhD Protein Kinase CK2 as emerging oncology target: Lessons from the CIGB-300 peptide inhibitor. Head of the Molecular Oncology Laboratory and Cancer Council at the CIGB Cuba
Yasser Perera, PhD

Targeting of Protein Kinase CK2-mediated phoshorylation in Acute Myeloid Leukemia (AML).

Molecular Oncology Laboratory. Cancer Department. Biomedical Research Area. CIGB Cuba
Andrew Sewell, PhD Pending Title Distinguished Research Professor and Wellcome Trust Senior Investigator, Infection & Immunity, Cardiff University School of Medicine, UK UK
Katherine Borden, PhD Targeting post-transcriptional regulation in cancer Principal Investigator, Structure and Function of the Cell Nucleus research unit, Institute for Research in Immunology and Cancer. Professor, Department of Pathology and Cell Biology, Faculty of Medicine, Université de Montréal, Canada. Canada
Renier J. Brentjens, MD, PhD Pending Title Memorial Sloan Kettering Cancer Center. Department of Medicine, Leukemia Service. New York. EE.UU
Jose R. Conejo-Garcia, MD, PhD Pending Title Chair, Department of Immunology. Moffitt Cancer Center, Tampa, USA EE.UU
Frank J. Rauscher, III, Ph.D Gene regulation and crosstalk amongst innate immune factors in the Tumor Microenvironment:  treating the tumor  as an organ Caspar Wistar Professor and Founder, The Gene Expression and Regulation Program Wistar Professor, Department of Genetics, University of Pennsylvania, USA EE.UU

Everett Meyer M.D. Ph.D.

Pending Title

Medical and Scientific Director, Cellular Therapy Facility,
Stanford Health Care
Assistant Professor of Medicine,
Blood and Marrow Transplantation, Stanford University

EE.UU

Luis Graca, MD. PhD.

Pending Title

Associate Professor, Head of Lymphocyte Regulation Laboratory, Faculdade de Medicina da Universidade de Lisboa, Portugal.

EE.UU

David Klatzmann, MD. PhD.

Pending Title

Lab Director, Professor of Immunology, Chief of Biotherapy, Coordinator of the Inflammatory-Immunopathology-Immunotherapy department and Coordinator of the Clinical Investigation Center in Biotherapy at Pierre and Marie Curie Medical School and Pitié-Salpêtrière hospital.

EE.UU

Willem van Eden

Pending Title

Professor, Department of Infectious Diseases and Immunology, Universiteit Utrecht.

EE.UU